Transarterial treatment of colorectal cancer liver metastases with irinotecan-loaded drug-eluting beads: Technical recommendations

Riccardo Lencioni, Camillo Aliberti, Thierry De Baere, Ricardo Garcia-Monaco, Govindarajan Narayanan, Elizabeth O'Grady, William S. Rilling, Duncan Walker, Robert C.G. Martin

    Résultats de recherche: Contribution à un journalArticleRevue par des pairs

    52 Citations (Scopus)

    Résumé

    Transcatheter hepatic arterial administration of irinotecan-loaded drug-eluting beads (DEBIRI) is used to treat liver-only or liver-dominant metastatic disease from colorectal cancer (CRC). Eligibility for DEBIRI should be established in each individual patient by a multidisciplinary team based on comprehensive clinical, imaging, and laboratory assessment. Standardization of DEBIRI technique and protocols would be expected to lead to improved efficacy and safety. The present article provides a set of technical recommendations for the use of DEBIRI in the treatment of hepatic CRC metastases.

    langue originaleAnglais
    Pages (de - à)365-369
    Nombre de pages5
    journalJournal of Vascular and Interventional Radiology
    Volume25
    Numéro de publication3
    Les DOIs
    étatPublié - 5 mars 2014

    Contient cette citation